Nu Skin Enterprises, Inc. (NUS)
NYSE · Consumer Defensive · Household & Personal Products
$4.63+0.43%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $225M
- Forward P/E
- 4.0
- Dividend yield
- 5.2%
- 52-week range
- $4.45 – $11.67
- 52-week change
- −58.51%
- EPS (trailing)
- −$4.51
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $1.5B (−14.25%)
- Net income
- $160M
- Operating margin
- 4.4%
- Diluted EPS
- $3.18
- Free cash flow
- $46.0M
From the company’s annual report on SEC EDGAR.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers.
Headquarters: Provo, United States · 2,800 employees · nuskin.com